Opportunities in Interventional and Diagnostic Imaging by Using High-Performance Low-Field-Strength MRI

被引:259
作者
Campbell-Washburn, Adrienne E. [1 ]
Ramasawmy, Rajiv [1 ]
Restivo, Matthew C. [1 ]
Bhattacharya, Ipshita [1 ]
Basar, Burcu [1 ]
Herzka, Daniel A. [1 ]
Hansen, Michael S. [1 ]
Rogers, Toby [1 ]
Bandettini, W. Patricia [1 ]
McGuirt, Delaney R. [1 ]
Mancini, Christine [1 ]
Grodzki, David [2 ]
Schneider, Rainer [2 ]
Majeed, Waqas [3 ]
Bhat, Himanshu [3 ]
Xue, Hui [4 ]
Moss, Joel [5 ]
Malayeri, Ashkan A. [6 ]
Jones, Elizabeth C. [6 ]
Koretsky, Alan P. [7 ]
Kellman, Peter [4 ]
Chen, Marcus Y. [1 ]
Lederman, Robert J. [1 ]
Balaban, Robert S. [4 ]
机构
[1] NHLBI, NIH, Cardiovasc Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA
[2] Siemens Healthcare GmbH, Erlangen, Germany
[3] Siemens Med Solut Inc, Malvern, PA USA
[4] NHLBI, NIH, Syst Biol Ctr, Div Intramural Res, 10 Ctr Dr,Bldg 10,Room 4C-1581, Bethesda, MD 20892 USA
[5] NHLBI, NIH, Pulmonary Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA
[6] NIH, Dept Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA
[7] NINDS, NIH, Lab Funct & Mol Imaging, Div Intramural Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HUMAN LUNG; NOISE; RELAXATION; SYSTEM; OXYGEN; ECHO;
D O I
10.1148/radiol.2019190452
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Commercial low-field-strength MRI systems are generally not equipped with state-of-the-art MRI hardware, and are not suitable for demanding imaging techniques. An MRI system was developed that combines low field strength (0.55 T) with high-performance imaging technology. Purpose: To evaluate applications of a high-performance low-field-strength MRI system, specifically MRI-guided cardiovascular catheterizations with metallic devices, diagnostic imaging in high-susceptibility regions, and efficient image acquisition strategies. Materials and Methods: A commercial 1.5-T MRI system was modified to operate at 0.55 T while maintaining high-performance hardware, shielded gradients (45 mT/m; 200 T/m/sec), and advanced imaging methods. MRI was performed between January 2018 and April 2019. T1, T2, and T2* were measured at 0.55 T; relaxivity of exogenous contrast agents was measured; and clinical applications advantageous at low field were evaluated. Results: There were 83 0.55-T MRI examinations performed in study participants (45 women; mean age, 34 years +/- 13). On average, T1 was 32% shorter, T2 was 26% longer, and T2* was 40% longer at 0.55 T compared with 1.5 T. Nine metallic interventional devices were found to be intrinsically safe at 0.55 T (<1 degrees C heating) and MRI-guided right heart catheterization was performed in seven study participants with commercial metallic guidewires. Compared with 1.5 T, reduced image distortion was shown in lungs, upper airway, cranial sinuses, and intestines because of improved field homogeneity. Oxygen inhalation generated lung signal enhancement of 19% +/- 11 (standard deviation) at 0.55 T compared with 7.6% +/- 6.3 at 1.5 T (P = .02; five participants) because of the increased T1 relaxivity of oxygen (4.7-24 mmHg(-1)sec(-1)). Efficient spiral image acquisitions were amenable to low field strength and generated increased signal-to-noise ratio compared with Cartesian acquisitions (P < .02). Representative imaging of the brain, spine, abdomen, and heart generated good image quality with this system. Conclusion: This initial study suggests that high-performance low-field-strength MRI offers advantages for MRI-guided catheterizations with metal devices, MRI in high-susceptibility regions, and efficient imaging. (C) RSNA, 2019
引用
收藏
页码:384 / 393
页数:10
相关论文
共 34 条
  • [1] ASTM International, 2009, F218209 ASTM INT
  • [2] Measurement of cerebral blood volume in humans using hyperoxic MRI contrast
    Bulte, Daniel
    Chiarelli, Peter
    Wise, Richard
    Jezzard, Peter
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 26 (04) : 894 - 899
  • [3] Right heart catheterization using metallic guidewires and low SAR cardiovascular magnetic resonance fluoroscopy at 1.5 Tesla: first in human experience
    Campbell-Washburn, Adrienne E.
    Rogers, Toby
    Stine, Annette M.
    Khan, Jaffar M.
    Ramasawmy, Rajiv
    Schenke, William H.
    McGuirt, Delaney R.
    Mazal, Jonathan R.
    Grant, Laurie P.
    Grant, Elena K.
    Herzka, Daniel A.
    Lederman, Robert J.
    [J]. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2018, 20
  • [4] Real-Time Distortion Correction of Spiral and Echo Planar Images Using the Gradient System Impulse Response Function
    Campbell-Washburn, Adrienne E.
    Xue, Hui
    Lederman, Robert J.
    Faranesh, Anthony Z.
    Hansen, Michael S.
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2016, 75 (06) : 2278 - 2285
  • [5] T1 relaxation time constants, influence of oxygen, and the oxygen transfer function of the human lung at 1.5 T-A meta-analysis
    Dietrich, Olaf
    Gaass, Thomas
    Reiser, Maximilian F.
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2017, 86 : 252 - 260
  • [6] Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging
    Edelman, RR
    Hatabu, H
    Tadamura, E
    Li, W
    Prasad, PV
    [J]. NATURE MEDICINE, 1996, 2 (11) : 1236 - 1239
  • [7] Golden-Angle Radial Sparse Parallel MRI: Combination of Compressed Sensing, Parallel Imaging, and Golden-Angle Radial Sampling for Fast and Flexible Dynamic Volumetric MRI
    Feng, Li
    Grimm, Robert
    Block, Kai Tobias
    Chandarana, Hersh
    Kim, Sungheon
    Xu, Jian
    Axel, Leon
    Sodickson, Daniel K.
    Otazo, Ricardo
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2014, 72 (03) : 707 - 717
  • [8] Cardiovascular MRI with ferumoxytol
    Finn, J. P.
    Nguyen, K. -L.
    Han, F.
    Zhou, Z.
    Salusky, I.
    Ayad, I.
    Hu, P.
    [J]. CLINICAL RADIOLOGY, 2016, 71 (08) : 796 - 806
  • [9] Lymphangioleiomyomatosis
    Johnson, Simon R.
    Taveira-DaSilva, Angelo M.
    Moss, Joel
    [J]. CLINICS IN CHEST MEDICINE, 2016, 37 (03) : 389 - +
  • [10] Konings MK, 2000, J MAGN RESON IMAGING, V12, P79, DOI 10.1002/1522-2586(200007)12:1<79::AID-JMRI9>3.3.CO